BidaskClub upgraded shares of Natus Medical (NASDAQ:BABY) from a sell rating to a hold rating in a research note published on Saturday.
BABY has been the subject of several other research reports. Roth Capital set a $39.00 price objective on shares of Natus Medical and gave the stock a buy rating in a research note on Tuesday, February 27th. Zacks Investment Research downgraded shares of Natus Medical from a buy rating to a hold rating in a research note on Tuesday, December 26th. William Blair downgraded shares of Natus Medical from an outperform rating to a market perform rating in a research note on Monday, January 8th. Finally, Benchmark reaffirmed a buy rating and set a $49.00 target price (down from $55.00) on shares of Natus Medical in a research report on Tuesday, January 16th. One analyst has rated the stock with a sell rating, two have issued a hold rating and two have assigned a buy rating to the company’s stock. The company currently has a consensus rating of Hold and an average price target of $44.33.
Shares of Natus Medical (NASDAQ:BABY) opened at $33.80 on Friday. The company has a debt-to-equity ratio of 0.37, a current ratio of 3.32 and a quick ratio of 2.54. The stock has a market cap of $1,105.90, a PE ratio of -54.52 and a beta of 0.55. Natus Medical has a 12 month low of $28.00 and a 12 month high of $43.60.
Natus Medical (NASDAQ:BABY) last announced its quarterly earnings data on Wednesday, February 7th. The medical equipment provider reported $0.42 earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of $0.54 by ($0.12). The firm had revenue of $131.40 million during the quarter, compared to the consensus estimate of $131.38 million. Natus Medical had a positive return on equity of 11.36% and a negative net margin of 4.05%. The firm’s revenue for the quarter was up 22.0% on a year-over-year basis. During the same period in the previous year, the business earned $0.51 EPS. equities analysts forecast that Natus Medical will post 1.63 EPS for the current year.
Natus Medical declared that its Board of Directors has approved a share buyback program on Thursday, February 22nd that authorizes the company to buyback $30.00 million in outstanding shares. This buyback authorization authorizes the medical equipment provider to repurchase shares of its stock through open market purchases. Shares buyback programs are usually an indication that the company’s board believes its stock is undervalued.
In other news, Director Ken Ludlum sold 4,000 shares of the firm’s stock in a transaction that occurred on Friday, March 2nd. The shares were sold at an average price of $31.68, for a total transaction of $126,720.00. Following the transaction, the director now directly owns 93,825 shares of the company’s stock, valued at $2,972,376. The sale was disclosed in a filing with the SEC, which is accessible through this hyperlink. Company insiders own 5.50% of the company’s stock.
Several large investors have recently modified their holdings of BABY. Millennium Management LLC purchased a new position in shares of Natus Medical during the fourth quarter worth approximately $10,445,000. Cambiar Investors LLC purchased a new position in Natus Medical during the fourth quarter valued at approximately $8,970,000. WCM Investment Management CA increased its holdings in Natus Medical by 503.8% during the fourth quarter. WCM Investment Management CA now owns 267,850 shares of the medical equipment provider’s stock valued at $10,232,000 after buying an additional 223,490 shares during the period. Renaissance Technologies LLC purchased a new position in Natus Medical during the fourth quarter valued at approximately $6,733,000. Finally, Deutsche Bank AG increased its holdings in Natus Medical by 435.2% during the fourth quarter. Deutsche Bank AG now owns 162,001 shares of the medical equipment provider’s stock valued at $6,186,000 after buying an additional 131,730 shares during the period. 95.76% of the stock is currently owned by institutional investors and hedge funds.
COPYRIGHT VIOLATION NOTICE: “Natus Medical (BABY) Upgraded to Hold at BidaskClub” was first reported by The Ledger Gazette and is the sole property of of The Ledger Gazette. If you are viewing this article on another publication, it was illegally stolen and reposted in violation of United States and international trademark & copyright laws. The legal version of this article can be read at https://ledgergazette.com/2018/03/21/natus-medical-baby-upgraded-to-hold-at-bidaskclub.html.
Natus Medical Company Profile
Natus Medical Incorporated is a provider of newborn care and neurology healthcare products and services used for the screening, diagnosis, detection, treatment, monitoring and tracking of common medical ailments in newborn care, hearing impairment, neurological dysfunction, epilepsy, sleep disorders, neuromuscular diseases and balance and mobility disorders.
Receive News & Ratings for Natus Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Natus Medical and related companies with MarketBeat.com's FREE daily email newsletter.